When is waiver of consent appropriate in a neonatal clinical trial?
It is difficult to do scientifically rigorous research on treatments that must be administered urgently or emergently. Therefore, such treatments are often provided without a strong evidence base. Research would be facilitated if it were permissible to waive the requirement for parental consent. How...
Gespeichert in:
| Veröffentlicht in: | Pediatrics (Evanston) 2014-11, Vol.134 (5), p.1006-1012 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1012 |
|---|---|
| container_issue | 5 |
| container_start_page | 1006 |
| container_title | Pediatrics (Evanston) |
| container_volume | 134 |
| creator | Schreiner, Mark S Feltman, Dalia Wiswell, Thomas Wootton, Susan Arnold, Cody Tyson, Jon Lantos, John D |
| description | It is difficult to do scientifically rigorous research on treatments that must be administered urgently or emergently. Therefore, such treatments are often provided without a strong evidence base. Research would be facilitated if it were permissible to waive the requirement for parental consent. However, that raises a different set of concerns. Federal regulations allow waiver of the requirement for consent but only if studies meet certain conditions. Institutional review boards must decide whether those conditions are met. Sometimes, reasonable people disagree. We present and analyze a protocol for which investigators request a waiver of consent. |
| doi_str_mv | 10.1542/peds.2014-0207 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4533281</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A389557999</galeid><sourcerecordid>A389557999</sourcerecordid><originalsourceid>FETCH-LOGICAL-c456t-852f02d5590d964b4705481af3147fdcb131304eaf869efca4e5d7834984fbb13</originalsourceid><addsrcrecordid>eNpdkc1vVCEUxYnR2LG6dWlI3Lh54-XrPdhomolfSZNu2rgkDA-mNAw84U2t_315mdpoV5DcH4dz7kHoLYE1EZx-nNxY1xQI74DC8AytCCjZcTqI52gFwEjHAcQJelXrDQBwMdCX6IQKKgcu-hXa_Lx2CYeKf5tw6wrOHtucqkszNtNU8lSCmR0OCRucXE5mNhHbGFKw7TK3afz8Gr3wJlb35uE8RVdfv1xuvnfnF99-bM7OO9u-mjspqAc6CqFgVD3f8gEEl8R4RvjgR7sljDDgznjZK-et4U6Mg2RcSe63bXqKPh11p8N270bbTBYTdbO4N-WPzibo_ycpXOtdvtVcMEblIvDhQaDkXwdXZ70P1boYTYt2qJr0FIASonhD3z9Bb_KhpBZvoXrS98BYo7ojtTPR6ZDa6mZ3N9sco9s53dJvLvQZk0qIQSnV-PWRtyXXWpx_NE9AL33qpU-99KmXPtuDd_9GfsT_FsjuAZWTmmM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1626166033</pqid></control><display><type>article</type><title>When is waiver of consent appropriate in a neonatal clinical trial?</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Schreiner, Mark S ; Feltman, Dalia ; Wiswell, Thomas ; Wootton, Susan ; Arnold, Cody ; Tyson, Jon ; Lantos, John D</creator><creatorcontrib>Schreiner, Mark S ; Feltman, Dalia ; Wiswell, Thomas ; Wootton, Susan ; Arnold, Cody ; Tyson, Jon ; Lantos, John D</creatorcontrib><description>It is difficult to do scientifically rigorous research on treatments that must be administered urgently or emergently. Therefore, such treatments are often provided without a strong evidence base. Research would be facilitated if it were permissible to waive the requirement for parental consent. However, that raises a different set of concerns. Federal regulations allow waiver of the requirement for consent but only if studies meet certain conditions. Institutional review boards must decide whether those conditions are met. Sometimes, reasonable people disagree. We present and analyze a protocol for which investigators request a waiver of consent.</description><identifier>ISSN: 0031-4005</identifier><identifier>EISSN: 1098-4275</identifier><identifier>DOI: 10.1542/peds.2014-0207</identifier><identifier>PMID: 25287456</identifier><identifier>CODEN: PEDIAU</identifier><language>eng</language><publisher>United States: American Academy of Pediatrics</publisher><subject>Care and treatment ; Clinical trials ; Consent ; Diseases ; Emergency Medical Services - ethics ; Emergency Medical Services - methods ; Ethical aspects ; Ethics Rounds ; Evidence-based medicine ; Humans ; Infant, Newborn ; Infants (Newborn) ; Informed Consent - ethics ; Neonatal diseases ; Parental Consent - ethics ; Parents & parenting ; Pediatrics ; Protocol ; Randomized Controlled Trials as Topic - ethics ; Randomized Controlled Trials as Topic - methods ; Review boards ; Risk factors</subject><ispartof>Pediatrics (Evanston), 2014-11, Vol.134 (5), p.1006-1012</ispartof><rights>Copyright © 2014 by the American Academy of Pediatrics.</rights><rights>Copyright American Academy of Pediatrics Nov 2014</rights><rights>Copyright © 2014 by the American Academy of Pediatrics 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c456t-852f02d5590d964b4705481af3147fdcb131304eaf869efca4e5d7834984fbb13</citedby><cites>FETCH-LOGICAL-c456t-852f02d5590d964b4705481af3147fdcb131304eaf869efca4e5d7834984fbb13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25287456$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schreiner, Mark S</creatorcontrib><creatorcontrib>Feltman, Dalia</creatorcontrib><creatorcontrib>Wiswell, Thomas</creatorcontrib><creatorcontrib>Wootton, Susan</creatorcontrib><creatorcontrib>Arnold, Cody</creatorcontrib><creatorcontrib>Tyson, Jon</creatorcontrib><creatorcontrib>Lantos, John D</creatorcontrib><title>When is waiver of consent appropriate in a neonatal clinical trial?</title><title>Pediatrics (Evanston)</title><addtitle>Pediatrics</addtitle><description>It is difficult to do scientifically rigorous research on treatments that must be administered urgently or emergently. Therefore, such treatments are often provided without a strong evidence base. Research would be facilitated if it were permissible to waive the requirement for parental consent. However, that raises a different set of concerns. Federal regulations allow waiver of the requirement for consent but only if studies meet certain conditions. Institutional review boards must decide whether those conditions are met. Sometimes, reasonable people disagree. We present and analyze a protocol for which investigators request a waiver of consent.</description><subject>Care and treatment</subject><subject>Clinical trials</subject><subject>Consent</subject><subject>Diseases</subject><subject>Emergency Medical Services - ethics</subject><subject>Emergency Medical Services - methods</subject><subject>Ethical aspects</subject><subject>Ethics Rounds</subject><subject>Evidence-based medicine</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Infants (Newborn)</subject><subject>Informed Consent - ethics</subject><subject>Neonatal diseases</subject><subject>Parental Consent - ethics</subject><subject>Parents & parenting</subject><subject>Pediatrics</subject><subject>Protocol</subject><subject>Randomized Controlled Trials as Topic - ethics</subject><subject>Randomized Controlled Trials as Topic - methods</subject><subject>Review boards</subject><subject>Risk factors</subject><issn>0031-4005</issn><issn>1098-4275</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkc1vVCEUxYnR2LG6dWlI3Lh54-XrPdhomolfSZNu2rgkDA-mNAw84U2t_315mdpoV5DcH4dz7kHoLYE1EZx-nNxY1xQI74DC8AytCCjZcTqI52gFwEjHAcQJelXrDQBwMdCX6IQKKgcu-hXa_Lx2CYeKf5tw6wrOHtucqkszNtNU8lSCmR0OCRucXE5mNhHbGFKw7TK3afz8Gr3wJlb35uE8RVdfv1xuvnfnF99-bM7OO9u-mjspqAc6CqFgVD3f8gEEl8R4RvjgR7sljDDgznjZK-et4U6Mg2RcSe63bXqKPh11p8N270bbTBYTdbO4N-WPzibo_ycpXOtdvtVcMEblIvDhQaDkXwdXZ70P1boYTYt2qJr0FIASonhD3z9Bb_KhpBZvoXrS98BYo7ojtTPR6ZDa6mZ3N9sco9s53dJvLvQZk0qIQSnV-PWRtyXXWpx_NE9AL33qpU-99KmXPtuDd_9GfsT_FsjuAZWTmmM</recordid><startdate>201411</startdate><enddate>201411</enddate><creator>Schreiner, Mark S</creator><creator>Feltman, Dalia</creator><creator>Wiswell, Thomas</creator><creator>Wootton, Susan</creator><creator>Arnold, Cody</creator><creator>Tyson, Jon</creator><creator>Lantos, John D</creator><general>American Academy of Pediatrics</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>U9A</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201411</creationdate><title>When is waiver of consent appropriate in a neonatal clinical trial?</title><author>Schreiner, Mark S ; Feltman, Dalia ; Wiswell, Thomas ; Wootton, Susan ; Arnold, Cody ; Tyson, Jon ; Lantos, John D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c456t-852f02d5590d964b4705481af3147fdcb131304eaf869efca4e5d7834984fbb13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Care and treatment</topic><topic>Clinical trials</topic><topic>Consent</topic><topic>Diseases</topic><topic>Emergency Medical Services - ethics</topic><topic>Emergency Medical Services - methods</topic><topic>Ethical aspects</topic><topic>Ethics Rounds</topic><topic>Evidence-based medicine</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Infants (Newborn)</topic><topic>Informed Consent - ethics</topic><topic>Neonatal diseases</topic><topic>Parental Consent - ethics</topic><topic>Parents & parenting</topic><topic>Pediatrics</topic><topic>Protocol</topic><topic>Randomized Controlled Trials as Topic - ethics</topic><topic>Randomized Controlled Trials as Topic - methods</topic><topic>Review boards</topic><topic>Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schreiner, Mark S</creatorcontrib><creatorcontrib>Feltman, Dalia</creatorcontrib><creatorcontrib>Wiswell, Thomas</creatorcontrib><creatorcontrib>Wootton, Susan</creatorcontrib><creatorcontrib>Arnold, Cody</creatorcontrib><creatorcontrib>Tyson, Jon</creatorcontrib><creatorcontrib>Lantos, John D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Pediatrics (Evanston)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schreiner, Mark S</au><au>Feltman, Dalia</au><au>Wiswell, Thomas</au><au>Wootton, Susan</au><au>Arnold, Cody</au><au>Tyson, Jon</au><au>Lantos, John D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>When is waiver of consent appropriate in a neonatal clinical trial?</atitle><jtitle>Pediatrics (Evanston)</jtitle><addtitle>Pediatrics</addtitle><date>2014-11</date><risdate>2014</risdate><volume>134</volume><issue>5</issue><spage>1006</spage><epage>1012</epage><pages>1006-1012</pages><issn>0031-4005</issn><eissn>1098-4275</eissn><coden>PEDIAU</coden><abstract>It is difficult to do scientifically rigorous research on treatments that must be administered urgently or emergently. Therefore, such treatments are often provided without a strong evidence base. Research would be facilitated if it were permissible to waive the requirement for parental consent. However, that raises a different set of concerns. Federal regulations allow waiver of the requirement for consent but only if studies meet certain conditions. Institutional review boards must decide whether those conditions are met. Sometimes, reasonable people disagree. We present and analyze a protocol for which investigators request a waiver of consent.</abstract><cop>United States</cop><pub>American Academy of Pediatrics</pub><pmid>25287456</pmid><doi>10.1542/peds.2014-0207</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0031-4005 |
| ispartof | Pediatrics (Evanston), 2014-11, Vol.134 (5), p.1006-1012 |
| issn | 0031-4005 1098-4275 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4533281 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Care and treatment Clinical trials Consent Diseases Emergency Medical Services - ethics Emergency Medical Services - methods Ethical aspects Ethics Rounds Evidence-based medicine Humans Infant, Newborn Infants (Newborn) Informed Consent - ethics Neonatal diseases Parental Consent - ethics Parents & parenting Pediatrics Protocol Randomized Controlled Trials as Topic - ethics Randomized Controlled Trials as Topic - methods Review boards Risk factors |
| title | When is waiver of consent appropriate in a neonatal clinical trial? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T00%3A05%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=When%20is%20waiver%20of%20consent%20appropriate%20in%20a%20neonatal%20clinical%20trial?&rft.jtitle=Pediatrics%20(Evanston)&rft.au=Schreiner,%20Mark%20S&rft.date=2014-11&rft.volume=134&rft.issue=5&rft.spage=1006&rft.epage=1012&rft.pages=1006-1012&rft.issn=0031-4005&rft.eissn=1098-4275&rft.coden=PEDIAU&rft_id=info:doi/10.1542/peds.2014-0207&rft_dat=%3Cgale_pubme%3EA389557999%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1626166033&rft_id=info:pmid/25287456&rft_galeid=A389557999&rfr_iscdi=true |